Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Blast crisis
MeSH D001752 - blast crisis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015464:
Bcr-abl positive chronic myelogenous leukemia
47 Companies
13 Drugs
$
Success rate
D002471:
Neoplastic cell transformation
0 Companies
0 Drugs
Success rate
D001752:
Blast crisis
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
25
%
2/8
Phase 2
0
%
0/21
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Servier
Pegaspargase
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use